Boston Scientific | BSX - Marktkapitalisierung

Aktienkurs
57.60
Täglich Wechseln
0.45 0.79%
Monatlich
-8.21%
Jährlich
-44.18%
Q2 Prognose
60.74




Marktkapitalisierung Veränderung Datum
Abbott USD 168.02B 10.39B 2026-04
AtriCure USD 1.97B 215M 2025-12
Avanos Medical USD 521M 15M 2025-12
Baxter International USD 8.97B 296M 2026-05
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Boston Scientific USD 90.36B 2.9B 2026-04
CONMED USD 1.11B 45M 2026-04
Cooper Companies USD 15.95B 2.05B 2025-12
Danaher USD 130.07B 1.61B 2026-04
Dexcom USD 23.25B 922M 2026-05
Edwards Lifesciences USD 47.05B 884M 2026-04
Globus Medical USD 11.69B 3.95B 2025-12
Illumina USD 20.14B 2.26B 2026-05
Insulet USD 20B 1.74B 2025-12
Integra LifeSciences USD 967M 150M 2025-12
Intuitive Surgical USD 159.96B 3.77B 2026-04
J&J USD 561.65B 17.5B 2026-04
Masimo USD 6.84B 839M 2025-12
Merit Medical Systems USD 3.95B 159M 2026-05
Stryker USD 119.9B 5.95B 2026-05
Tandem Diabetes Care USD 1.49B 670M 2025-12
Teleflex USD 5.39B 91M 2025-12
Zimmer Biomet Holdings USD 17.01B 488M 2026-04